The Antipsychotic Effects of ECT: A Review of Possible Mechanisms

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of ECT

• Publication date

  2014-06-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1097/YCT.0000000000000131PMID 24810776
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Efficacy of anti-inflammatory agents to improve symptoms in patients with schizophrenia: an update.

  2014cited by this paper
• Effectiveness and tolerance of anti‐inflammatory drugs' add‐on therapy in major mental disorders: a systematic qualitative review

  2014cited by this paper
• Meta-analysis of oxidative stress in schizophrenia.

  2013cited by this paper
• Parkinson Disease Psychosis: Update

  2013cited by this paper
• Serum and gene expression profile of cytokines in first-episode psychosis

  2013cited by this paper
• A systematic, quantitative review of blood autoantibodies in schizophrenia.

  2013cited by this paper
• Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies.

  2013cited by this paper
• Meta-analysis of lymphocytes in schizophrenia: clinical status and antipsychotic effects.

  2013cited by this paper
• BDNF-TrkB signaling and neuroprotection in schizophrenia.

  2013cited by this paper
• Increased cerebrospinal fluid interleukin-6 levels in patients with schizophrenia and those with major depressive disorder.

  2013cited by this paper
• Changes of Cytokine Profiles During Electroconvulsive Therapy in Patients With Major Depression

  2013cited by this paper
• Adjunctive use of nonsteroidal anti-inflammatory drugs for schizophrenia: a meta-analytic investigation of randomized controlled trials.

  2013cited by this paper
• Global decrease of serotonin-1A receptor binding after electroconvulsive therapy in major depression measured by PET

  2012cited by this paper
• Effects of repeated electroconvulsive shock on methamphetamine-induced behavioral abnormalities in mice.

  2012cited by this paper
• Electroconvulsive seizure promotes spine maturation in newborn dentate granule cells in adult rat

  2012cited by this paper
• Contemporary use and practice of electroconvulsive therapy worldwide

  2012cited by this paper
• Urine catecholamine levels are not influenced by electroconvulsive therapy in depression or schizophrenia over the long term

  2012influential reference
• Is Relapse in Schizophrenia an Immune-Mediated Effect?

  2012cited by this paper
• Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis

  2011cited by this paper
• Effects of chronic antidepressant drug administration and electroconvulsive shock on activity of dopaminergic neurons in the ventral tegmentum.

  2011cited by this paper
• Brain-Derived Neurotrophic Factor and Electroconvulsive Therapy in a Schizophrenic Patient With Treatment-Resistant Paranoid-Hallucinatory Symptoms

  2011influential reference
• Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects.

  2011cited by this paper
• Acute and chronic effects of electroconvulsive treatment on oxidative parameters in schizophrenia patients.

  2011cited by this paper
• Vascular Endothelial Growth Factor (VEGF) serum concentration during electroconvulsive therapy (ECT) in treatment resistant depressed patients

  2011cited by this paper
• Electroconvulsive therapy has acute immunological and neuroendocrine effects in patients with major depressive disorder.

  2011cited by this paper
• The role of serotonin receptors in the action of atypical antipsychotic drugs.

  2011influential reference
• Autoimmune diseases and severe infections as risk factors for schizophrenia: a 30-year population-based register study.

  2011cited by this paper
• Remission of persistent methamphetamine-induced psychosis after electroconvulsive therapy: presentation of a case and review of the literature.

  2010cited by this paper
• Effect of electroconvulsive therapy on 5-HT1A receptor binding in patients with depression: a PET study with [11C]WAY 100635.

  2010cited by this paper
• The Level of Serum Brain-Derived Neurotrophic Factor Is Associated With the Therapeutic Efficacy of Modified Electroconvulsive Therapy in Chinese Patients With Depression

  2010cited by this paper
• A meta-analysis of cytokines in major depression.

  2010cited by this paper
• Prenatal infection and schizophrenia: a review of epidemiologic and translational studies.

  2010cited by this paper
• An inverse relationship between cortisol and BDNF levels in schizophrenia: data from human postmortem and animal studies.

  2010cited by this paper
• Effect of electroconvulsive therapy on brain 5-HT2 receptors in major depression

  2010cited by this paper
• Improvement of schizophrenia with electroconvulsive therapy and serum brain‐derived neurotrophic factor levels: Lack of association in a pilot study

  2010cited by this paper
• Dopamine and psychosis: theory, pathomechanisms and intermediate phenotypes.

  2010cited by this paper
• The neurodevelopmental hypothesis of schizophrenia, revisited.

  2009cited by this paper
• Neuroinflammation in Schizophrenia-Related Psychosis: A PET Study

  2009cited by this paper
• Serum brain-derived neurotrophic factor (BDNF) is not associated with response to electroconvulsive therapy (ECT): a pilot study in drug resistant depressed patients.

  2009cited by this paper
• Neurotrophic factors in serum following ECT: A pilot study

  2009cited by this paper
• Using bioinformatic tools.

  2009cited by this paper
• Common polygenic variation contributes to risk of schizophrenia and bipolar disorder

  2009cited by this paper
• Plasma Brain-Derived Neurotrophic Factor in treatment-resistant depressed patients receiving electroconvulsive therapy.

  2009cited by this paper
• Serum markers of brain-cell damage and C-reactive protein are unaffected by electroconvulsive therapy

  2008influential reference
• CSF monoamine metabolites and neuropeptides in depressed patients before and after electroconvulsive therapy

  2008cited by this paper
• Increase in Plasma Proinflammatory Cytokines After Electroconvulsive Therapy in Patients With Depressive Disorder

  2008cited by this paper
• Brain-Derived Neurotropic Factor/TrkB Signaling in the Pathogenesis and Novel Pharmacotherapy of Schizophrenia

  2008cited by this paper
• Effect of quetiapine in psychotic Parkinson's disease patients: A double‐blind labeled study of 3 months' duration

  2007cited by this paper
• The Successful Use of Electroconvulsive Therapy in a Patient With Interferon-Induced Psychotic Depression

  2007cited by this paper
• Comparative study of clozapine, electroshock and the combination of ECT with clozapine in treatment-resistant schizophrenic patients.

  2007cited by this paper
• Metabolic Correlates of Antidepressant and Antipsychotic Response in Patients With Psychotic Depression Undergoing Electroconvulsive Therapy

  2007cited by this paper
• A Case Study of a Patient With a Medication-resistant Major Depression Treated With Ketamine Infusion Followed by Pharmacotherapy Alone vs. Combined ECT and Pharmacotherapy

  2007cited by this paper
• Differential effects of long-term treatment with typical and atypical antipsychotics on NGF and BDNF levels in rat striatum and hippocampus.

  2006cited by this paper
• Prevention of oxidative stress-mediated neuropathology and improved clinical outcome by adjunctive use of a combination of antioxidants and omega-3 fatty acids in schizophrenia

  2006cited by this paper
• Association of schizophrenia and autoimmune diseases: linkage of Danish national registers.

  2006cited by this paper
• Electroconvulsive Therapy (ECT) increases serum Brain Derived Neurotrophic Factor (BDNF) in drug resistant depressed patients.

  2006cited by this paper
• The Combined Use of Electroconvulsive Therapy and Antipsychotics in Patients With Schizophrenia

  2005cited by this paper
• The effect of electroconvulsive shock seizures on behaviour induced by dopaminergic agonists and on immobility in the Porsolt test.

  2004cited by this paper
• Raised Plasma Levels of Tumor Necrosis Factor &agr; in Patients With Depression: Normalization During Electroconvulsive Therapy

  2003cited by this paper
• Gene Profile of Electroconvulsive Seizures: Induction of Neurotrophic and Angiogenic Factors

  2003cited by this paper
• Elevated Interleukin-6 in the Cerebrospinal Fluid of a Previously Delineated Schizophrenia Subtype

  2003cited by this paper
• Acute effects of electroconvulsive therapy on lymphocyte natural killer cell activity in patients with major depression.

  2002cited by this paper
• Effect of electroconvulsive therapy on hematological parameters.

  2001cited by this paper
• Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial.

  2001cited by this paper
• ECT Remission Rates in Psychotic Versus Nonpsychotic Depressed Patients: A Report from CORE

  2001cited by this paper
• The Effect of Olanzapine Treatment on Monoamine Metabolite Concentrations in the Cerebrospinal Fluid of Schizophrenic Patients

  2001cited by this paper
• Increased neurogenesis in a model of electroconvulsive therapy.

  2000cited by this paper
• Psychotic depression occurring after stopping interferon-alpha.

  1999cited by this paper
• Short-term effect of combined ECT and neuroleptic therapy in treatment-resistant schizophrenia.

  1999cited by this paper
• Accumulation of macrophages in the CSF of schizophrenic patients during acute psychotic episodes.

  1999cited by this paper
• Neurotrophins Rescue Cerebellar Granule Neurons from Oxidative Stress‐Mediated Apoptotic Death: Selective Involvement of Phosphatidylinositol 3‐Kinase and the Mitogen‐Activated Protein Kinase Pathway

  1998cited by this paper
• Enhancement of dopamine-mediated behaviour by the NMDA antagonists MK-801 and CPP: similarities with repeated electroconvulsive shock

  1997cited by this paper
• Abnormal distributions of T-lymphocyte subsets in the cerebrospinal fluid of patients with acute schizophrenia.

  1995cited by this paper
• Concurrent analysis of neuropeptides and biogenic amines in brain tissue of rats treated with electroconvulsive stimuli.

  1995cited by this paper
• The profile of C‐reactive proteins in functional psychotic states in a cohort in Nigeria

  1993cited by this paper
• Immune Changes Induced by Electroconvulsive Therapy (ECT) a

  1992cited by this paper
• Hypothalamic--pituitary--adrenal axis and monoamine transmitter activity in depression: a pilot study of central and peripheral effects of electroconvulsive therapy.

  1991cited by this paper
• Electroconvulsive Therapy Increases Plasma Levels of Interleukin‐6 a

  1990cited by this paper
• Treatment of Phencyclidine-Associated Psychosis with ECT.

  1988cited by this paper
• The Effect of Electroconvulsive Therapy on CSF Amine Metabolites in Schizophrenic Patients

  1988cited by this paper
• A controlled study of cellular immune function in affective disorders before and during somatic therapy.

  1985cited by this paper
• The efficacy of ECT in phencyclidine-induced psychosis.

  1984cited by this paper
• Reduction of MOPEG levels in cerebrospinal fluid of psychotic women after electroconvulsive treatment

  1979influential reference
• Antipsychotic drugs, neurotransmitters, and schizophrenia.

  1978cited by this paper
• Effect of chlorpromazine treatment on monoamine metabolite levels in cerebrospinal fluid of psychotic patients

  1977influential reference

• Effect of Electroconvulsive Therapy (ECT) on IL-1β, IP-10, IL-17, TNFα, IL-10 and Soluble IL-2 Receptor in Treatment-Resistant Schizophrenia (TRS) Patients—A Preliminary Study

  2025cites this paper
• Addressing the stigma and promoting awareness: Electroconvulsive therapy in Pakistan

  2024cites this paper
• Changes in IL-6, IL-12, IL-5, IL-10 and TGF-β1 Concentration in Patients with Treatment-Resistant Schizophrenia (TRS) Following Electroconvulsive Therapy (ECT)—A Pilot Study

  2024cites this paper
• Effectiveness of the Combined Antipsychotic and Electroconvulsive Therapy (ECT) in Patients with First Episode Psychosis

  2024cites this paper
• History of tobacco smoking and alcohol use can predict the effectiveness of electroconvulsive therapy in individuals with schizophrenia: A multicenter clinical trial.

  2024cites this paper
• The Influence of Electroconvulsive Therapy (ECT) on Brain-Derived Neurotrophic Factor (BDNF) Plasma Level in Patients with Schizophrenia—A Systematic Review and Meta-Analysis

  2023cites this paper
• Transcranial Magnetic Stimulation in the Treatment of Positive, Negative, and Cognitive Symptoms of Psychosis

  2023cites this paper
• Neuroleptic-induced tardive dystonia in young patients suffering from psychosis

  2022cites this paper
• Comparative Study of the Effect of Midazolam Administration Before and after Seizures on the Prevention of Complications in Children Undergoing Electroconvulsive Therapy Compared with a Control Group

  2022cites this paper
• Electroconvulsive Therapy in Psychiatric Disorders: A Narrative Review Exploring Neuroendocrine–Immune Therapeutic Mechanisms and Clinical Implications

  2022cites this paper
• Progressive Changes in Brain Regional Homogeneity Induced by Electroconvulsive Therapy Among Patients With Schizophrenia

  2021cites this paper
• Ketamine treatment protects against oxidative damage and the immunological response induced by electroconvulsive therapy

  2021cites this paper
• Sudden Death After Electroconvulsive Therapy in the Context of Coronavirus Disease 2019

  2021cites this paper
• DEPRESSION: AN OVERVIEW IN THE PATHOPHYSIOLOGY AND TREATMENT

  2021cites this paper
• ECT augmentation of antipsychotics in severely ill schizophrenia: a naturalistic, observational study

  2020cites this paper
• Altered functional connectivity of the thalamus induced by modified electroconvulsive therapy for schizophrenia.

  2020cites this paper
• Translating preclinical findings in clinically relevant new antipsychotic targets: focus on the glutamatergic postsynaptic density. Implications for treatment resistant schizophrenia.

  2019cites this paper
• Elevated serum vascular endothelial growth factor in treatment-resistant schizophrenia treated with electroconvulsive therapy: Positive association with therapeutic effects

  2019cites this paper
• ECT-induced brain plasticity correlates with positive symptom improvement in schizophrenia by voxel-based morphometry analysis of grey matter.

  2019cites this paper
• Low-charge electrotherapy for patients with schizophrenia: A double-blind, randomised controlled pilot clinical trial.

  2019cites this paper
• Electroconvulsive therapy for treatment-resistant schizophrenia.

  2019cites this paper
• Decreased Clostridium Abundance after Electroconvulsive Therapy in the Gut Microbiota of a Patient with Schizophrenia

  2019cites this paper
• Auditory verbal hallucinations in schizophrenia: current perspectives in brain stimulation treatments

  2019cites this paper
• L’électroconvulsivothérapie en psychiatrie et neurologie

  2019cites this paper
• Comparative psychopharmacology of autism and psychotic-affective disorders suggests new targets for treatment

  2019cites this paper
• NDT_A_168801 2105..2117

  2019cites this paper
• When Clozapine Fails: Augmentation Strategies in the Management of Clozapine-Resistant Schizophrenia

  2018cites this paper
• Effect of Electroconvulsive Therapy on Medial Prefrontal &ggr;-Aminobutyric Acid Among Schizophrenia Patients: A Proton Magnetic Resonance Spectroscopy Study

  2018cites this paper
• Impacts of Electroconvulsive Therapy on 1-Year Outcomes in Patients With Schizophrenia: A Controlled, Population-Based Mirror-Image Study

  2018cites this paper
• The Immediate Early Gene Egr3 Is Required for Hippocampal Induction of Bdnf by Electroconvulsive Stimulation

  2018cites this paper
• Increased resting-state global functional connectivity density of default mode network in schizophrenia subjects treated with electroconvulsive therapy.

  2017cites this paper
• Alterations in the Prescription of Psychotropic Drugs After Electroconvulsive Therapy Immediately in Patients with Schizophrenia

  2017cites this paper
• Anesthetic considerations for pediatric electroconvulsive therapy

  2017cites this paper
• The under portrayal of Electroconvulsive Therapy (ECT) procedure in the Asian media

  2017cites this paper
• Anesthesia for electroconvulsive therapy

  2017cites this paper
• How Electroconvulsive Therapy Works?: Understanding the Neurobiological Mechanisms

  2017cites this paper
• Psychotic symptoms as a complication of electroconvulsive therapy - a case report.

  2017cites this paper
• Reversal of cerebral glucose hypometabolism on positron emission tomography with electroconvulsive therapy in an elderly patient with a psychotic episode

  2016cites this paper
• Diffusion Imaging of White Matter In Schizophrenia: Progress and Future Directions.

  2016cites this paper
• Charting the Course of Electroconvulsive Therapy: Where Have We Been and Where Are We Headed?

  2016cites this paper
• Electroconvulsive therapy for post-traumatic stress disorder: efficacy, mechanisms and a hypothesis for new directions

  2016cites this paper
• Electroconvulsive therapy for treatment-resistant schizophrenia

  2015cites this paper
• Transcutaneous noninvasive vagus nerve stimulation (tVNS) in the treatment of schizophrenia: a bicentric randomized controlled pilot study

  2015cites this paper
• Management of Treatment-Refractory Schizophrenia

  2014cites this paper
• Searching for the mechanism(s) of ECT's therapeutic effect.

  2014cites this paper